InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the complete record of transactions filed by Azab Mohammad, 董事. Insider active across 4 companies, notably Xenon Pharmaceuticals Inc.. Aggregated, 11 reports have been recorded. Split: 2 buys · 0 sell. Total volume traded: €5k. Activity tracked since 15 December 2021. The latest transaction was disclosed on 9 January 2026 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
11 条申报中的 11 条
AZAB MOHAMMAD is Administrateur and has reported 11 filings in total. Across the 11 sampled filings between 2021-12-17 and 2026-01-13, the most common transaction nature is Attribution, with EUR 5436 of buys and EUR 0 of sells. He is a director at LISATA THERAPEUTICS, INC., DURECT CORP and Xenon Pharmaceuticals Inc.